Brief: Shionogi & Co Ltd Announces Agreements On Collaborative Research With Peptidream For New Peptide Drug Conjugate(Pdc) Discovery
23/01/2019 06:04
(Repeats with PeptiDream stock code)
Jan 23 (Reuters) - Shionogi & Co Ltd 4507.T :
* SHIONOGI & CO LTD ANNOUNCES AGREEMENTS ON COLLABORATIVE
RESEARCH
WITH PEPTIDREAM INC 4587.T FOR NEW PEPTIDE DRUG CONJUGATE
(PDC) DISCOVERY
Source text for Eikon: ID:nTSMW70df1
Further company coverage: 4507.T
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner